Saint Vincent and the Grenadines

Last Updated 26 July 2021.

5 Vaccines Approved for Use in Saint Vincent and the Grenadines

• Moderna
  mRNA-1273

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 64 countries

  21 trials in 4 countries

  Approval Source: health.gov.vc

  RNA

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 97 countries

  24 trials in 16 countries

  Approval Source: health.gov.vc

  RNA

• Gamaleya
  Sputnik V

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 70 countries

  19 trials in 7 countries

  Approval Source: tass.com

  Non Replicating Viral Vector

• Janssen (Johnson & Johnson)
  Ad26.COV2.S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 56 countries

  11 trials in 17 countries

  Approval Source: health.gov.vc

  Non Replicating Viral Vector

• Serum Institute of India
  Covishield (Oxford/AstraZeneca formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 45 countries

  2 trials in 1 country

  Approval Source: loopnewscaribbean.com

  Non Replicating Viral Vector

0 Vaccines in Clinical Trials in Saint Vincent and the Grenadines